Bispecific CD19/CD22 CAR T Cells Active in Pediatric Relapsed ALL OncLive, 29 Apr 2020 Haneen Shalabi, DO Treatment with CD19/22 chimeric antigen receptor (CAR) CAR T cells induced a promising response in patients…